[Media Releases] Beyond child's play: LegoChem's platform to expedite drug discovery (BioWorld, 3 Sep 2014)

Title:  Beyond child's play: LegoChem's platform to expedite drug discovery

Publication: BioWorld / Marie Powers (Staff Writer)

Date: 3 Sep 2014

URL: link to website (subscription required for full contents)

Summary

·         Legochem Biosciences Inc. (LCB) boasts an intuitive name, hearkening to the use of Lego-like scaffolds to enable the discovery of drug candidates. But the platform is more than a toy for scientists.

About LegoChem Biosciences

LegoChem Biosciences, Inc. (LCB) is a research-based biotechnology company dedicated to discovering, developing, and commercializing innovative medicines by leveraging our chemistry expertise to make conventional biologics targeted and more potent for the benefit of patients with diseases of high unmet medical needs. We are advancing sustainable pipelines in therapeutic areas in antibiotics, anti-coagulants, oncology, antibody-drug conjugate (ADC), and protein-drug conjugate (PDC).